Median Technologies
Created in 2002
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
904 9,022Activities
Technologies
Entity types
Location
06560 Valbonne, France
Valbonne
France
Employees
Scale: 201-500
Estimated: 233
SIREN
443676309Engaged corporates
25
10 10Added in Motherbase
6 years, 2 months ago
biotech Value proposition
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and eyonisTM, our AI/ML tech-based suite of software as medical devices (SaMD) help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME).
clinical trials, imaging CRO, oncology clinical trials, iRECIST, RECIST 1.1, iBiopsy, Artificial Intelligence, Deep Learning, Big Data, Cloud Computing, Immuno-oncology, Liver diseases, Image processing, Software as Medical Device, Data Science, eyonis, and Medical image processingOriginal language
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and eyonisTM, our AI/ML tech-based suite of software as medical devices (SaMD) help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME).
Home - Median Technologies
https://mediantechnologies.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Maison de l'Intelligence Artificielle | Other 29 Nov 2024 | | |
 SATT Sud-Est Research, National and local authorities, Research Services | SATT Sud-Est Research, National and local authorities, Research Services | Other 14 Jun 2024 | | |
 Le Journal des Entreprises Media, Newspaper Publishing | Le Journal des Entreprises Media, Newspaper Publishing | Other 28 Apr 2024 | | |
 Viva Technology Trade show, IT Services and IT Consulting | Viva Technology Trade show, IT Services and IT Consulting | Other 28 Apr 2024 | | |
 | Rise Partners | Other 8 Dec 2022 | | |
 La Tribune Media, Newspapers | La Tribune Media, Newspapers | Other 16 Dec 2023 | | |
 | Ministère de la Santé | Other 12 Oct 2023 | | |
 Régions de France NGO, Think Tank, Government Relations Services | Régions de France NGO, Think Tank, Government Relations Services | Other 28 Jun 2023 | | |
 CCI France Chamber of commerce, Government Administration | CCI France Chamber of commerce, Government Administration | Other 28 Jun 2023 | | |
 Amgen Biotechnology, Biotechnology Research | Amgen Biotechnology, Biotechnology Research | Other 6 Feb 2023 | | |